The China Electronics and Shulan Health-backed medical data processing software provider collected $36.3m in a Tencent-led round that included Sinopharm.

Internet group Tencent led a RMB250m ($36.3m) series C round for China-based medical data processing software developer Synyi yesterday. Sinopharm Capital, the private equity arm of pharmaceutical firm Sinopharm, also took part in the round, according to a statement on the WeChat account of existing Synyi backer ZhenFund. Founded in 2016 and previously known as…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.